Maternal Influenza Vaccine

Cross-source consensus on Maternal Influenza Vaccine from 1 sources and 5 claims.

1 sources · 5 claims

Uses

The pooled maternal influenza vaccine effect estimate was OR 0.79 with 21% vaccine effectiveness against all-cause ALRI hospitalisation in infants under six months. — Systematic review and meta-analysis of the non-specific and broader impact of respiratory vaccines on acute lower respiratory infections in young children
Four studies qualified for the maternal influenza vaccine meta-analysis against all-cause ALRI in infants under six months. — Systematic review and meta-analysis of the non-specific and broader impact of respiratory vaccines on acute lower respiratory infections in young children
The maternal influenza vaccine meta-analysis had moderate, statistically significant heterogeneity. — Systematic review and meta-analysis of the non-specific and broader impact of respiratory vaccines on acute lower respiratory infections in young children
Maternal influenza vaccination is described as the only available influenza prevention strategy for infants under six months. — Systematic review and meta-analysis of the non-specific and broader impact of respiratory vaccines on acute lower respiratory infections in young children
Maternal influenza vaccination is a WHO priority and has been introduced in more than 85 Member States. — Systematic review and meta-analysis of the non-specific and broader impact of respiratory vaccines on acute lower respiratory infections in young children